MedPath
HSA Approval

LACTEOL FORT CAPSULE

SIN09791P

LACTEOL FORT CAPSULE

LACTEOL FORT CAPSULE

May 27, 1998

AMSCO HEALTHCARE MARKETING PTE. LTD.

AMSCO HEALTHCARE MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAMSCO HEALTHCARE MARKETING PTE. LTD.
Licence HolderAMSCO HEALTHCARE MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

CAPSULE

Dosage and administration To be taken at the first sign of diarrhea. ![Lacteol Fort Capsule Dosage Table 1](https://cdn.medpath.com/drug/dosage/20240520/8c37e4dfdd8ffd36818d6f23233e296a.png) The 2nd dose can be taken 6–8 hours after the 1st dose.

ORAL

Medical Information

Indications Symptomatic treatment of diarrhea.

A07FA01

lactic acid producing organisms

Manufacturer Information

AMSCO HEALTHCARE MARKETING PTE. LTD.

ADARE PHARMACEUTICALS SAS

Active Ingredients

CULTURE MEDIUM (NEUTRALIZED AND LYOPHILIZED)

80 mg

LACTOBACILLUS (LYOPHILIZED MICROBIAL BODIES)

5 billion

Documents

Package Inserts

Lacteol Fort Cap PI.pdf

Approved: February 3, 2016

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LACTEOL FORT CAPSULE - HSA Approval | MedPath